Document Library

Document filter
Document Order


Poster - Iron Deficiency Anemia - for Midwives

o Poster aimed at midwives regarding Iron Deficiency Anaemia

21st March, 2018 : Microsoft Powerpoint Document (273K)

Download Document

Data Collection Tool Instructions

Instructions for use of the data collection tool

21st March, 2018 : Adobe PDF Document (106K)

Download Document

Obstretric anaemia data collection tool

An Excel spreadsheet to enable data collection and analysis for an Obstetric Anaemia audit / project (this spreadsheet requires Macros to be enabled)

21st March, 2018 : (24K)

Download Document

Managing patients on monoclonal antibody therapies

Managing patients on monoclonal antibody therapies -information for hospital transfusion laboratories, transfusion practitioners & Haematology clinical teams

21st March, 2018 : Adobe PDF Document (248K)

Download Document

3cellscreen3531profile.pdf

20th March, 2018 : Adobe PDF Document (35K)

Download Document

Certificate 3 Cellscreen 3531.pdf

20th March, 2018 : Adobe PDF Document (130K)

Download Document

Certificate IgG 3299.pdf

20th March, 2018 : Adobe PDF Document (129K)

Download Document

Essential info - therapeutic monoclonal antibodies & blood transfusion

Essential information for managing patients on monoclonal antibody therapies – an information pack for hospital transfusion laboratories, transfusion practitioners & Haematology clinical teams.

19th March, 2018 : Adobe PDF Document (726K)

Download Document

Therapeutic monoclonal antibodies & blood transfusion - PPP

Managing patients on monoclonal antibody therapies – an information pack for hospital transfusion laboratories, transfusion practitioners & Haematology clinical teams Treatments which include monoclonal antibody-based therapies are being identified and developed for use in clinical practice, in the treatment of patients with haematological malignancies. Recent guidance from the National Institute of Health and Care Excellence (NICE) has supported the use of the monoclonal anti-CD38 therapy, Daratumumab (Darzalex) in patients with relapsed or refractory Multiple Myeloma (MM). Other monoclonal therapies currently at clinical trial stage include Isatuximab, another anti-CD38 therapy for the treatment of relapsed or refractory MM patients, and an anti-CD47 (Hu5F9-G4), for use in patients with relapsed or refractory Acute Myeloid Leukaemia (AML) or Myelodysplastic Syndrome (MDS). (CAMELLIA Trial).

19th March, 2018 : Adobe PDF Document (726K)

Download Document

Panel 1 profile 3400.pdf

Panel 1 profile 3400.pdf

19th March, 2018 : Adobe PDF Document (171K)

Download Document